Fantasy Football - Footballguys Forums
This is a sample guest message. Register a free account today to become a member! Once signed in, you'll be able to participate on this site by adding your own topics and posts, as well as connect with other members through your own private inbox!
Stock Thread (19 Viewers)
- Thread starter St. Louis Bob
- Start date
Nugget
Footballguy
I am getting out now of F now at 7.28. I don’t know how high it can go without restoring the dividend, and I want to by some more S&P500 on sale.Yeah, thanks for this. I started looking at this when you posted that. Ended up buying some.
Punxsutawney Phil
Footballguy
Bought a few shares in the treasure hunters omex. They are waiting on a nafta ruling in 60 days to see if they have a stake in a phosphate find. I saw "billions" in the article and it is a small company, so figured this could be one that gets a big bump on any positive news. I also have been following it and there were a few bumps in the stock a month or so ago after investors meetings. So some big guys liked what they said.
Last edited by a moderator:
-OZ-
Footballguy
Last edited by a moderator:
McBokonon
Footballguy
I imagine they’ll release it. Not sure what you should do because our goals might be different, but I’m putting in a small stake now and then holding until the first FDA decision. That was my original plan but then it doubled so I sold (thankfully.)
I think they are an interesting stock just wanted your opinion on the release since the company has just said they are reviewing the first one.
Have they said when the FDA decision may be? I think I’d want to keep it long term if the decision is good.
Last edited by a moderator:
McBokonon
Footballguy
Not 100% sure but they want to start deploying early 2021 so maybe in the next couple months?
Yeah, if it gets approved I’m diving in.
Appreciate the insight. Pretty sure my $28.50 hasn’t hit. We’ll see as it closes and go from there.
beef
Footballguy
Good, no OTC fees for when I sell.
Quite the rally back this afternoon. 10.40 now, low of 8.99 today.
Or it could be a way to own the most expensive shares in quit awhile. It won't uplift tomorrow because no institution would be buy at $10.40. Il'' take the gain on my cydy shares I flipped to HEN though.
"Nano-X (NASDAQ:NNOX) is the most blatant stock promotion we have seen in years," says Andrew Left.
"The company has valued themselves at less than $1 per share. SEC should investigate false claims. No R&D, no FDA and no product, yet trades at over $2B market cap."
Left's target price: $0.
beef
Footballguy
Nano-X Imaging Ltd NASDAQ: NNOX Based in Israel
There's some hit pieces out there. Kushner will save us.
Last edited by a moderator:
That’s old man, they already shaved off over a $1B of that. They made out like crazy.
SFBayDuck
Footballguy
beef
Footballguy
Bob Sacamano
Footballguy
Who here is in BE? Pretty sure a few people were. How we feeling about it for the long-term?
KGB
Footballguy
Don Hutson
Footballguy
Humanigen Announces Pricing of Public Offering of Common Stock and Commencement of Trading on Nasdaq Under the Symbol “HGEN”
https://www.humanigen.com/press/Humanigen-Announces-Pricing-of-Public-Offering-of-Common-Stock-and-Commencement-of-Trading-on-Nasdaq-Under-the-Symbol-“HGEN”
Burlingame, CA, September 17, 2020 – Humanigen, Inc.(“Humanigen”), a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidate lenzilumab, announced today that it has priced its underwritten public offering of 8,000,000 shares of common stock at a public offering price of $8.50 per share, resulting in gross proceeds to Humanigen of approximately $68 million, before deducting underwriting discounts and commissions and offering expenses. The offering is expected to close on or about September 22, 2020. Humanigen also granted the underwriters a 30-day option to purchase up to an additional 1,200,000 shares at the public offering price, less underwriting discounts and commissions.
J.P. Morgan and Jefferies are acting as joint book-running managers for the offering. Bryan, Garnier & Co. is acting as the European lead manager and H.C. Wainwright & Co., National Securities Corporation and Roth Capital Partners are acting as co-managers for the offering.
As previously announced, Humanigen’s stock will commence trading on the Nasdaq Capital Market on Friday, September 18, 2020, under the symbol “HGEN.”
Humanigen intends to use the net proceeds from the offering to support its manufacturing, production and commercial preparation activities relating to lenzilumab as a potential therapy for COVID-19 patients and for general corporate purposes.
The shares are being offering by Humanigen pursuant to a shelf registration statement (including a prospectus) on Form S-3 that was previously filed with and declared effective by the U.S. Securities and Exchange Commission (“SEC”). The offering is being made only by means of the written prospectus and prospectus supplement that form a part of the registration statement. A preliminary prospectus supplement relating to and describing the terms of the offering was filed with the SEC on September 15, 2020 and is available on the SEC’s website at www.sec.gov. A final prospectus supplement relating to the offering will be filed with the SEC, and also will be available on the SEC’s website.
https://www.humanigen.com/press/Humanigen-Announces-Pricing-of-Public-Offering-of-Common-Stock-and-Commencement-of-Trading-on-Nasdaq-Under-the-Symbol-“HGEN”
Burlingame, CA, September 17, 2020 – Humanigen, Inc.(“Humanigen”), a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidate lenzilumab, announced today that it has priced its underwritten public offering of 8,000,000 shares of common stock at a public offering price of $8.50 per share, resulting in gross proceeds to Humanigen of approximately $68 million, before deducting underwriting discounts and commissions and offering expenses. The offering is expected to close on or about September 22, 2020. Humanigen also granted the underwriters a 30-day option to purchase up to an additional 1,200,000 shares at the public offering price, less underwriting discounts and commissions.
J.P. Morgan and Jefferies are acting as joint book-running managers for the offering. Bryan, Garnier & Co. is acting as the European lead manager and H.C. Wainwright & Co., National Securities Corporation and Roth Capital Partners are acting as co-managers for the offering.
As previously announced, Humanigen’s stock will commence trading on the Nasdaq Capital Market on Friday, September 18, 2020, under the symbol “HGEN.”
Humanigen intends to use the net proceeds from the offering to support its manufacturing, production and commercial preparation activities relating to lenzilumab as a potential therapy for COVID-19 patients and for general corporate purposes.
The shares are being offering by Humanigen pursuant to a shelf registration statement (including a prospectus) on Form S-3 that was previously filed with and declared effective by the U.S. Securities and Exchange Commission (“SEC”). The offering is being made only by means of the written prospectus and prospectus supplement that form a part of the registration statement. A preliminary prospectus supplement relating to and describing the terms of the offering was filed with the SEC on September 15, 2020 and is available on the SEC’s website at www.sec.gov. A final prospectus supplement relating to the offering will be filed with the SEC, and also will be available on the SEC’s website.
skycriesmary
Climbing up the Walls
Cheers. You and me both. *sigh*SFBayDuck said:
beef said:
SFBayDuck said:
beef said:
Bankers getting cheap shares. I’m seeing this one through. EUA in 4Q = $75 stock price.
To do a deal with the devil? Lol. Might be tempted. I am interested to see how the uplisting goes to make me feel good about finally getting out of that game. If you can’t get the uplisting right that’s a problem. It really isn’t hard to do, I mean these SPACs pop up like every day and companies like NNOX do IPOs with no revenue, etc.
Not for a year unless like FMCI it turns into a long term hold. It’s in my IRA so no tax implications at all. Just doing what @McBokonon is doing and waiting for FDA approval. That said if it gets back towards the highs before then, probably sell and wait for another downturn or approval.
Last edited by a moderator:
Already have a boatload. It will drop today as the market is getting flooded with cheap shares. 70 days worth of stock is being sold at $8.50. Looks like HGEN just gave all their existing shareholders the middle finger.
beef
Footballguy
Not me. Have enough that I'll ride out.
$8.50 +6.51 (327.13%), but really down 1.90 from yesterday's 10.40.
Don Hutson
Footballguy
Do you know that people are allowed to immediately sell the shares that they just bought for $8.50 or are you speculating that is the case?
Last edited by a moderator:
I'm speculating, but I assume shares in the green always go to the institutions. I read yesterday that institutions didn't have enough money to eat up a the Snowflake. If they don't flip these stocks, they won't have enough money for the numerous IPOs in the pipeline. It's such an issue that Kramer speculated the entire market will be held as people and institutions are exiting existing stocks to buy these IPOs.
Don Hutson
Footballguy
HGEN is the red right now Bid $8.65 Ask $8.70
beef
Footballguy
I got in to see if I could make a quick buck because it looked like an overreaction/oversold. It'll be hard not to cut in half at $35, completely out at $40 or sell enough to ride free shares.
Management ####### shareholders. Down 18% today. Pourhassen looks like Bezos today compared to HGEN mgmt. Love how they did the reverse split so they price shares below the NASDAQ threshold.
Don Hutson
Footballguy
HGEN went as low at $8.28 but it's $9.63 now.
Don Hutson
Footballguy
Your theory about institutions wanting money for IPOs makes sense. And HGEN's investors are almost entirely institutions. CYDY will explode if it ever gets on Nasdaq because it has an army of retail investors some of which can't buy currently i.e. Robinhooders.
Thoughts on ZM shooting up from $100 to $400 in the span of six months? I get that schools and businesses all around the country are using the platform but it feels like nothing special. Microsoft and others have competing platforms. Seems to me that it would only take one significant blip (like some kind of breach of privacy or server issues), or positive news on the vaccine front to cause it to drop hard. The puts on it are very expensive but I'm tempted to buy a couple with these thoughts in mind. For context, the P/E is 529.
beef
Footballguy
HGEN Institutional holdings, does that include these new shares? TD is showing 25.07%, but that may just include shares as of yesterday.
